Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro.
about
Redox interplay between mitochondria and peroxisomesDocosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cellsHypochlorous acid-mediated generation of glycerophosphocholine from unsaturated plasmalogen glycerophosphocholine lipids.Regional changes in CNS and retinal glycerophospholipid profiles with age: a molecular blueprintQuantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain.Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes.Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.Analytical methods for (oxidized) plasmalogens: Methodological aspects and applications.Early lipid changes in acute kidney injury using SWATH lipidomics coupled with MALDI tissue imaging.Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult miceMetabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2).Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes MellitusOxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.Structural and functional roles of ether lipids.Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport.Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether.Interactions of plasmalogens and their diacyl analogs with singlet oxygen in selected model systemsSynthesis and antioxidant properties of an unnatural plasmalogen analogue bearing a trans O-vinyl ether linkageStatin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia.Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids.Modified phosphatidylethanolamine as the active component of oxidized low density lipoprotein promoting platelet prothrombinase activity.Increasing plasmalogen levels protects human endothelial cells during hypoxia.Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers.Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses.Transbilayer distribution of aminophospholipids and the oxidative stability of their component polyunsaturated fatty acids.Oxidative environment causes molecular remodeling in embryonic heart-a metabolomic and lipidomic fingerprinting analysis.Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia.From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.Evidence that plasmalogen is protective against oxidative stress in the rat brain.Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.Experimental Periodontitis Results in Prediabetes and Metabolic Alterations in Brain, Liver and Heart: Global Untargeted Metabolomic Analyses
P2860
Q28394944-8320B6F1-96EA-47C3-BB95-3B7A970F5846Q28568993-DF631CCB-34BE-4CE8-836F-D2D8A9D9B860Q33280563-AF597A76-6096-4E9B-A6DE-9C5236FE0A24Q33567994-44EE6927-B7D8-423E-AEC6-8D25F1CC9BBDQ33634200-644BBFD8-DC5B-40F2-A6BF-9EFE17D0DC5AQ33842597-5E0E4BDE-5D0A-49D8-976E-F218E8B5B6A4Q33947437-96E94EB7-E8C3-4C6B-8094-C91347F30925Q34626206-225C5790-D7FC-4DFC-BD7B-AAB53E566AB7Q35533292-27F334EF-6BDE-4151-80A7-8515033954B3Q35934780-B1504362-6832-4934-95E0-D8B3AEA081F1Q36241433-A923CC83-FBF9-4156-92D9-3149C5AE1244Q36870879-F61493EC-2284-4320-8946-59A4901C0A9CQ37700127-2B62669C-2518-4794-9146-D31A5B60930BQ37847817-3A622788-18C3-4B07-AB33-23B8FE0E93C4Q38272446-7F2CC352-9BF6-4929-8821-FD2A22D81BD4Q39317295-E7C6E85C-596F-44C9-8BDB-1943C5478BBEQ40611683-E30F1C43-1FE6-4C00-8646-2C099AAAC2C5Q40969946-271B2218-0598-4008-9EB3-9C0F8229E6FFQ42120644-372BAB7F-F4B3-4845-8489-39DB5CBAD9DEQ42551256-7F244975-0C36-4F28-B171-B76ECB1FBDD1Q42725914-4179DC34-5E1E-4358-98D1-771CEC5609E4Q42993679-A1DAC2A6-385E-436B-9E08-7A61938426A0Q43559326-0298207B-0797-478D-A1C8-D0C8DE6A09BCQ44068495-197B9200-A6B2-4272-9808-CAC65F6C58E1Q44272190-24396303-D025-43F4-9B1F-3165740968BCQ44317083-F14A0341-0E6E-4F87-AE5C-C00C067ECC20Q45210068-EC3D7DAA-92A3-4C79-90A8-178E3635AD60Q46312759-BFDFC70E-3B0B-4BAB-977F-6190535339C6Q48090023-2A686105-F31A-4106-BF3E-84503B9245B1Q48159157-02D574B0-8486-48BE-B461-72F0151E75ABQ48498726-55D914B7-3052-4DA3-AC97-4E68A5E52AD4Q51737988-FEC9B8CB-9C82-481A-8431-6C7282E8DCDAQ57140240-FAF37270-2B41-44EB-A3F1-2340DB7C0E46
P2860
Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Delayed oxidative degradation ...... alogen phospholipids in vitro.
@en
Delayed oxidative degradation ...... alogen phospholipids in vitro.
@nl
type
label
Delayed oxidative degradation ...... alogen phospholipids in vitro.
@en
Delayed oxidative degradation ...... alogen phospholipids in vitro.
@nl
prefLabel
Delayed oxidative degradation ...... alogen phospholipids in vitro.
@en
Delayed oxidative degradation ...... alogen phospholipids in vitro.
@nl
P2093
P2860
P356
P1433
P1476
Delayed oxidative degradation ...... alogen phospholipids in vitro.
@en
P2093
P2860
P304
P356
10.1042/BJ3230807
P407
P478
323 ( Pt 3)
P577
1997-05-01T00:00:00Z